SAN DIEGO & EMERYVILLE, Calif.–(BUSINESS WIRE)–Family Eye Care Optometry and NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY) announced that Guru Sharma O.D. Ph.D., Optometrist at Family Eye Care Optometry and Assistant Professor at Western University of the Health Sciences’ College of Optometry, presented new research documenting the successful use of Avenova™ on patients with blepharitis during the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO). Dr. Sharma’s
PHOENIX & EMERYVILLE, Calif.–(BUSINESS WIRE)–Phoenix Eye Care and NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY) announced that Dr. Arthur B. Epstein, Director of Clinical Research and head of the Dry Eye – Ocular Surface Disease Center at Phoenix Eye Care, discussed the benefits of NovaBay’s Avenova™ lid & lash cleanser at the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO). The poster presentation was held today, May 6, from 11:00 a.m.–12:45 p.m. Centra
SUMMERVILLE, S.C.–(BUSINESS WIRE)–SCRA Technology Ventures company, FirstString Research, announces CRADA to advance therapeutic for diabetic keratopathy and persistent corneal defects.
AUSTIN, Texas–(BUSINESS WIRE)–Mati Therapeutics Inc. (“Mati”) announced today that it has been granted U.S. Patent No. 9,011,361 entitled “Lacrimal Implant Detection” and European Union Patent No. EP2614844 entitled “Drug Cores for Sustained Release of Therapeutic Agents.” These patents provide coverage for important elements of Mati’s novel punctal plug delivery system (“PPDS”) for treatment of ocular indications including certain features for detecting the implants in the puncta and in the
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/c33pgm/global_and) has announced the addition of the “Global and Chinese Soft Hydrophilic Contact Lens Industry, 2010-2020 Market Research Report” report to their…
NEW YORK–(BUSINESS WIRE)–Ophthotech announced that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present at the Bank of America Merrill Lynch 2015 Health Care Conference on May 13, 2015.
TAMPA, Fla.–(BUSINESS WIRE)–Retina Associates of Tampa pilot study suggests that single Ranibizumab injection with peripheral laser therapy can treat DME associated with peripheral retina nonperfusion.
DENVER–(BUSINESS WIRE)–Allegro Ophthalmics announced that it has begun enrolling patients in a Phase 2 clinical trial that will evaluate Luminate® in inducing PVD in patients with non-proliferative diabetic retinopathy.
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced two senior management appointments in commercialization and manufacturing. As discussed on its fourth quarter 2014 conference call, the Company will be making several key hires as it continues the transition from an R&D focused organization
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida Announces May 8 for Third Quarter Fiscal Year 2015 Financial Results and Release Date and Conference Call Information
IRVINE, Calif. & BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (the “Company”), announced today that its first quarter 2015 financial results will be released after the market closes on Thursday, May 7, 2015. Following the release, the Company will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company’s financial results and provide a general business and strategic update. Additionally, the Company
BOSTON–(BUSINESS WIRE)–Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing drug candidates for mitochondrial dysfunction, today announced expansion of its ophthalmology program.
COLUMBUS, Ohio–(BUSINESS WIRE)–The Cataract & Refractive Center of Ohio released an advisory alert to educate people across the Midwest about a new treatment for chronic eye problems suffered by millions of Americans. Those problems are often worse during the spring in the Midwest, when the air is flooded with pollen from maple trees and other plants. In the advisory, Alice T. Epitropoulos, MD, FACS, co-founder of The Eye Center of Columbus, explains that more than 23 million Americans su
TOKYO–(BUSINESS WIRE)–R-Tech Ueno (JASDAQ:4573) This is to announce that R-Tech Ueno, Ltd. (Head Office: Chiyoda-ku, Tokyo, CEO and President: Yukihiko Mashima, hereinafter referred to as “R-Tech Ueno”) has acquired the right to develop and commercia…
MURRIETA, Calif.–(BUSINESS WIRE)–II-VI Optical Systems (II-VI OS) will present at the SPIE-DSS show in Baltimore Maryland, April 20-23, 2015, Booth #725.
LONDON–(BUSINESS WIRE)–Technavio has published a new report on the smart glasses market for augmented reality (AR), which is expected to grow at a CAGR 194.2% from 2015-2019.
SUNNYVALE, Calif.–(BUSINESS WIRE)–Phase 3 trial data showed that IBI-10090 is highly effective in treating inflammation post cataract surgery.
PLEASANTON, Calif.–(BUSINESS WIRE)–Clarity Medical Systems, Inc., a developer and marketer of ophthalmic diagnostic imaging technologies, is pleased to announce that their product, RetCam, will be utilized to image premature infant eyes in a study to evaluate a potential new method for treating Retinopathy of Prematurity (ROP) using Lucentis™ (ranibizumab). “The use of RetCam in a study of this medical significance demonstrates the growing worldwide acceptance of RetCam for pediatric retinal
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida VP of Research to discuss company’s protein and antibody sustained delivery system at upcoming Ocular diseases and drug conference
LAKE FOREST, Calif.–(BUSINESS WIRE)–ReVision Optics®, Inc. (RVO), a leader in implantable inlay technology to treat presbyopia, reported a high level of satisfaction from a group of 58 patients treated for presbyopia at the Ultralase Clinics in the …